| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.6 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |